FCI
TAK icon

Financial Counselors Inc’s Takeda Pharmaceutical TAK Stock Holding History

Financial Counselors Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,817
Closed -$353K – 602
2024
Q3 		$353K Sell
24,817
-305
-1% -$4.33K 0.01% 483
2024
Q2 		$325K Sell
25,122
-253
-1% -$3.35K 0.01% 471
2024
Q1 		$352K Sell
25,375
-158
-0.6% -$2.3K 0.01% 466
2023
Q4 		$364K Sell
25,533
-126
-0.5% -$1.79K 0.01% 448
2023
Q3 		$397K Sell
25,659
-40
-0.2% -$619 0.01% 424
2023
Q2 		$404K Sell
25,699
-57
-0.2% -$934 0.01% 390
2023
Q1 		$424K Sell
25,756
-191
-0.7% -$3.04K 0.01% 383
2022
Q4 		$405K Sell
25,947
-85
-0.3% -$1.19K 0.01% 390
2022
Q3 		$338K Sell
26,032
-117
-0.4% -$1.63K 0.01% 400
2022
Q2 		$367K Sell
26,149
-1,687
-6% -$24.1K 0.01% 397
2022
Q1 		$399K Sell
27,836
-542
-2% -$7.96K 0.01% 386
2021
Q4 		$387K Sell
28,378
-406
-1% -$5.7K 0.01% 393
2021
Q3 		$471K Sell
28,784
-66
-0.2% -$1.11K 0.01% 379
2021
Q2 		$486K Sell
28,850
-492
-2% -$8.38K 0.01% 376
2021
Q1 		$536K Sell
29,342
-88
-0.3% -$1.58K 0.01% 360
2020
Q4 		$536K Sell
29,430
-105
-0.4% -$1.84K 0.01% 356
2020
Q3 		$527K Sell
29,535
-265
-0.9% -$4.83K 0.02% 339
2020
Q2 		$534K Sell
29,800
-63
-0.2% -$1.13K 0.02% 352
2020
Q1 		$453K Sell
29,863
-276
-0.9% -$5K 0.02% 319
2019
Q4 		$595K Sell
30,139
-186
-0.6% -$3.56K 0.02% 331
2019
Q3 		$522K Sell
30,325
-55
-0.2% -$951 0.02% 340
2019
Q2 		$538K Sell
30,380
-331
-1% -$6.02K 0.02% 332
2019
Q1 		$626K Buy
+30,711
New +$618K 0.03% 312

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Financial Counselors Inc's TAK Position: Q4 2024 in Review

Financial Counselors Inc sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 24,817 shares — an estimated $353K sold.

Financial Counselors Inc first reported a position in TAK in Q1 2019 and held it in 23 quarters. The position peaked at $626K in Q1 2019. 301 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

  • Financial Counselors Inc reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Financial Counselors Inc sold 24,817 Takeda Pharmaceutical shares in Q4 2024, an estimated $353K.
  • Financial Counselors Inc first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 23 quarters.
  • Financial Counselors Inc's Takeda Pharmaceutical position peaked at $626K in Q1 2019.
  • 301 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Financial Counselors Inc's 13F filing for Q4 2024, filed 12 Feb 2025.